Dynamics Driving the Chronic Inflammatory Demyelinating Polyneuropathy Market Dynamics The Chronic Inflammatory Demyelinating Polyneuropathy Market dynamics are strongly driven by the high cost and required chronic use of immunoglobulin therapies. Since IVIg and SCIg treatments are expensive and mandatory for managing the disease, favorable reimbursement policies in developed regions like North America and Europe are essential market enablers, ensuring sustained financial...